Menu
Back to Journals » OncoTargets and Therapy » Volume 10
RETRACTED ARTICLE: Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma
Authors Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J
Received 22 May 2016
Accepted for publication 17 September 2016
Published 14 February 2017 Volume 2017:10 Pages 847—857
DOI https://doi.org/10.2147/OTT.S113353
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Samir Farghaly
This paper has been retracted.
Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J. Onco Targets Ther. 2017;10:847–857.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images between Figure 1A, panel HGF, Adjacent normal tissues and Figure 2A, panel HCC tissues. In addition, there also appears to be duplication of images between Figure 4B and C.
The authors did not respond to our queries in regard to the alleged duplication, nor did they provide original data for their study. The Editor requested to retract the article and the authors were notified of this.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2017 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.